Researchers engineered T cells to be more efficient and precise in their ability to kill prostate cancer cells. T cell receptors are modified to improve durability of the bond with cancer cells.
The post Modifying T Cell Receptor Improves Targeted Cancer Therapy appeared first on GEN -…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Researchers found that acute kidney injury is triggered by ceramides that damage mitochondria in kidney proximal tubules, and that targeting how ceramides are made, either genetically or with a drug, prevented AKI in mice. The […]
SALT LAKE CITY, Feb. 20, 2025 /PRNewswire/ — OWL Planners, a Utah-based company, is excited to announce the official launch of its new range of essential document storage and next-of-kin preparation products. OWL Planners aims […]
– Company announces the appointment of Dr. David Bearss, CEO of Halia Therapeutics, as a member of the Board of Directors at BioUtah LEHI, Utah, Oct. 31, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical […]
Copyright © 2026 Biotech Networks
